The role of novel therapeutic approaches for prevention of allosensitization and antibody‐mediated rejection
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The role of novel therapeutic approaches for prevention of allosensitization and antibody‐mediated rejection
Authors
Keywords
-
Journal
AMERICAN JOURNAL OF TRANSPLANTATION
Volume 20, Issue S4, Pages 42-56
Publisher
Wiley
Online
2020-06-15
DOI
10.1111/ajt.15913
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Multi Targeted CAR-T Cell Therapies for B-Cell Malignancies
- (2019) Nirav N. Shah et al. Frontiers in Oncology
- A late B lymphocyte action in dysfunctional tissue repair following kidney injury and transplantation
- (2019) Pietro E. Cippà et al. Nature Communications
- Use of Eculizumab for Active Antibody-Mediated Rejection that Occurs Early Post-Kidney Transplantation
- (2019) Ek Khoon Tan et al. TRANSPLANTATION
- The Neonatal Fc Receptor: Key to Homeostasic Control of IgG and IgG‐Related Biopharmaceuticals
- (2019) William M. Baldwin et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Safety and efficacy of eculizumab for the prevention of antibody‐mediated rejection after deceased‐donor kidney transplantation in patients with preformed donor‐specific antibodies
- (2019) Denis Glotz et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Update on C1 Esterase Inhibitor (C1-INH) in Human Solid Organ Transplantation
- (2019) Mel Berger et al. TRANSPLANTATION
- Daratumumab in Sensitized Kidney Transplantation: Potentials and Limitations of Experimental and Clinical Use
- (2019) Jean Kwun et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Inebilizumab for the treatment of neuromyelitis optica spectrum disorder (N-MOmentum): a double-blind, randomised placebo-controlled phase 2/3 trial
- (2019) Bruce A C Cree et al. LANCET
- Implications of Fc Neonatal Receptor (FcRn) Manipulations for Transplant Immunotherapeutics
- (2019) Stanley C. Jordan et al. TRANSPLANTATION
- Safety and Preliminary Clinical Activity of REGN5458, an Anti-Bcma x Anti-CD3 Bispecific Antibody, in Patients with Relapsed/Refractory Multiple Myeloma
- (2019) Dennis Cooper et al. BLOOD
- Imlifidase Inhibits HLA Antibody-Mediated NK Cell Activation and Antibody-Dependent Cell-Mediated Cytotoxicity (ADCC) In Vitro
- (2019) Shili Ge et al. TRANSPLANTATION
- Three-Year Outcomes of a Randomized, Double-Blind, Placebo-Controlled Study Assessing Safety and Efficacy of C1 Esterase Inhibitor for Prevention of Delayed Graft Function in Deceased Donor Kidney Transplant Recipients
- (2019) Edmund Huang et al. Clinical Journal of the American Society of Nephrology
- Linking innate immunity and chronic antibody-mediated allograft rejection
- (2019) Ronald G. Gill et al. Current Opinion in Organ Transplantation
- A phase I/II, double-blind, placebo-controlled study assessing safety and efficacy of C1 esterase inhibitor for prevention of delayed graft function in deceased donor kidney transplant recipients
- (2018) Stanley C. Jordan et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Immunomodulatory effects of CD38-targeting antibodies
- (2018) Niels W.C.J. van de Donk IMMUNOLOGY LETTERS
- Complement-binding anti-HLA antibodies are independent predictors of response to treatment in kidney recipients with antibody-mediated rejection
- (2018) Denis Viglietti et al. KIDNEY INTERNATIONAL
- Design and preclinical characterization of ALXN1210: A novel anti-C5 antibody with extended duration of action
- (2018) Douglas Sheridan et al. PLoS One
- Novel Approaches to Block Complement
- (2018) Georg A. Böhmig et al. TRANSPLANTATION
- In vivo depletion of serum IgG by an affibody molecule binding the neonatal Fc receptor
- (2018) Johan Seijsing et al. Scientific Reports
- Dual targeting: Combining costimulation blockade and bortezomib to permit kidney transplantation in sensitized recipients
- (2018) Christopher K. Burghuber et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Antibody-Mediated Rejection of Solid-Organ Allografts
- (2018) Alexandre Loupy et al. NEW ENGLAND JOURNAL OF MEDICINE
- Novel Therapeutic Approaches to Allosensitization and Antibody-Medicated Rejection
- (2018) Stanley C. Jordan et al. TRANSPLANTATION
- Belatacept in renal transplant recipient with mild immunologic risk factor: A pilot prospective study (BELACOR)
- (2018) Claire Leibler et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Complement and Transplantation
- (2018) Julian K. Horwitz et al. CLINICS IN LABORATORY MEDICINE
- Antibody-mediated rejection across solid organ transplants: manifestations, mechanisms, and therapies
- (2017) Nicole M. Valenzuela et al. JOURNAL OF CLINICAL INVESTIGATION
- Complement-Activating Anti-HLA Antibodies in Kidney Transplantation: Allograft Gene Expression Profiling and Response to Treatment
- (2017) Carmen Lefaucheur et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- IgG Endopeptidase in Highly Sensitized Patients Undergoing Transplantation
- (2017) Stanley C. Jordan et al. NEW ENGLAND JOURNAL OF MEDICINE
- The FcRn inhibitor rozanolixizumab reduces human serum IgG concentration: A randomized phase 1 study
- (2017) Peter Kiessling et al. Science Translational Medicine
- Overriding TKI resistance of renal cell carcinoma by combination therapy with IL-6 receptor blockade
- (2017) Kei Ishibashi et al. Oncotarget
- Impact of Desensitization on Antiviral Immunity in HLA-Sensitized Kidney Transplant Recipients
- (2017) Mieko Toyoda et al. Journal of Immunology Research
- Plasma-Derived C1 Esterase Inhibitor for Acute Antibody-Mediated Rejection Following Kidney Transplantation: Results of a Randomized Double-Blind Placebo-Controlled Pilot Study
- (2016) R. A. Montgomery et al. AMERICAN JOURNAL OF TRANSPLANTATION
- HLA Class II Antibody Activation of Endothelial Cells Promotes Th17 and Disrupts Regulatory T Lymphocyte Expansion
- (2016) J. Lion et al. AMERICAN JOURNAL OF TRANSPLANTATION
- C1 Inhibitor in Acute Antibody-Mediated Rejection Nonresponsive to Conventional Therapy in Kidney Transplant Recipients: A Pilot Study
- (2016) D. Viglietti et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Daratumumab depletes CD38+ immune regulatory cells, promotes T-cell expansion, and skews T-cell repertoire in multiple myeloma
- (2016) J. Krejcik et al. BLOOD
- The biology behind interleukin-6 targeted interventions
- (2016) Xiao Liu et al. CURRENT OPINION IN RHEUMATOLOGY
- Anti-CD28 Antibody and Belatacept Exert Differential Effects on Mechanisms of Renal Allograft Rejection
- (2016) S. Ville et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Immunological characterization of de novo and recall alloantibody suppression by CTLA4Ig in a mouse model of allosensitization
- (2016) Irene Kim et al. TRANSPLANT IMMUNOLOGY
- Cutting Edge: CTLA-4Ig Inhibits Memory B Cell Responses and Promotes Allograft Survival in Sensitized Recipients
- (2015) Jianjun Chen et al. JOURNAL OF IMMUNOLOGY
- Cutting Edge: Circulating Plasmablasts Induce the Differentiation of Human T Follicular Helper Cells via IL-6 Production
- (2015) Konstantia-Maria Chavele et al. JOURNAL OF IMMUNOLOGY
- IL-6 as a keystone cytokine in health and disease
- (2015) Christopher A Hunter et al. NATURE IMMUNOLOGY
- A Phase I/II Placebo-Controlled Trial of C1-Inhibitor for Prevention of Antibody-Mediated Rejection in HLA Sensitized Patients
- (2015) Ashley A. Vo et al. TRANSPLANTATION
- The Efficacy and Safety of Subcutaneous Clazakizumab in Patients With Moderate-to-Severe Rheumatoid Arthritis and an Inadequate Response to Methotrexate: Results From a Multinational, Phase IIb, Randomized, Double-Blind, Placebo/Active-Controlled, Dose-Ra
- (2015) Michael E. Weinblatt et al. Arthritis & Rheumatology
- Increase of Th17 Cell Phenotype in Kidney Transplant Recipients with Chronic Allograft Dysfunction
- (2015) Byung Ha Chung et al. PLoS One
- The Biology and Medical Implications of Interleukin-6
- (2014) T. Tanaka et al. Cancer Immunology Research
- Plasmapheresis-resistant acute humoral rejection successfully treated with anti-C5 antibody
- (2013) Giulia Ghirardo et al. PEDIATRIC TRANSPLANTATION
- Evaluation of serum interleukin 6 and tumour necrosis factor alpha levels, and their association with various non-immunological parameters in renal transplant recipients
- (2013) GK Sonkar et al. SINGAPORE MEDICAL JOURNAL
- Eculizumab for Salvage Treatment of Refractory Antibody-Mediated Rejection in Kidney Transplant Patients: Case Reports
- (2013) B. Kocak et al. TRANSPLANTATION PROCEEDINGS
- Intravenous Immune Globulin in Autoimmune and Inflammatory Diseases
- (2012) Erwin W. Gelfand NEW ENGLAND JOURNAL OF MEDICINE
- Clinical Aspects of Intravenous Immunoglobulin Use in Solid Organ Transplant Recipients
- (2011) S. C. Jordan et al. AMERICAN JOURNAL OF TRANSPLANTATION
- A Phase III Study of Belatacept Versus Cyclosporine in Kidney Transplants from Extended Criteria Donors (BENEFIT-EXT Study)
- (2010) A. Durrbach et al. AMERICAN JOURNAL OF TRANSPLANTATION
- A Phase III Study of Belatacept-based Immunosuppression Regimens versus Cyclosporine in Renal Transplant Recipients (BENEFIT Study)
- (2010) F. Vincenti et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Daratumumab, a Novel Therapeutic Human CD38 Monoclonal Antibody, Induces Killing of Multiple Myeloma and Other Hematological Tumors
- (2010) M. de Weers et al. JOURNAL OF IMMUNOLOGY
- The Use of Antibody to Complement Protein C5 for Salvage Treatment of Severe Antibody-Mediated Rejection
- (2008) J. E. Locke et al. AMERICAN JOURNAL OF TRANSPLANTATION
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started